> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Workshop on Kidney Transplant Rejection Drugs
- URL: https://www.fdaweb.com/workshop-on-kidney-transplant-rejection-drugs/
- Published: 2017-04-05T12:00:00.000Z
- Updated: 2026-09-14T22:16:03.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5138385

*Federal Register* Notice: FDA has announced a 4/12 public workshop on new developments and scientific issues related to antibody mediated rejection (AMR) in kidney transplantation. The workshop is intended to provide information on various aspects of clinical development of medical products for prophylaxis and treatment of AMR in kidney transplant recipients, including clinical trial design and endpoints. The workshop will be held in Silver Spring, MD. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-04-05/pdf/2017-06700.pdf?ref=fdaweb.com).